section 8
on 28 Nov 2014
Last Applicant/ Owned by
Drottninggatan 98
Stockholm
SE
111 60
Serial Number
76207867 filed on 09th Feb 2001
Registration Number
3414817 registered on 22nd Apr 2008
Correspondent Address
Michael W. Garvey
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"ORPHAN"
In the statement column 1 line 8, "immuno comprised" should be deleted, and "immunocomprised" should be inserted. The design is a globe. Pharmaceuticals for the treatment of rare diseases, namely, in the field of cardiology, diseases affecting immunocompromised patients, genetic disorders, haematology, infectious diseases, metabolic disorders, oncology, pallative care, poison control, respirator Read More
Pharmaceuticals for the treatment of rare diseases, namely, in the field of cardiology, diseases affecting immunocompromised patients, genetic disorders, haematology, infectious diseases, metabolic disorders, oncology, pallative care, poison control, respiratory diseases, urology and psychiatric diseases
18th Feb 2002
18th Feb 2002
product research and development of prescription and over-the-counter drugs
18th Feb 2002
18th Feb 2002
No 76207867
No Service Mark
No MOB-35517
No
No
No
No
No
No
No
No
01.07.08 -
Globes with bars, bands, or wavy lines, excluding meridian or parallel lines
The design is a globe.
Status Date | Action Taken |
---|---|
28th Nov 2014 | CANCELLED SEC. 8 (6-YR) |
09th Sep 2008 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
09th Jun 2008 | ASSIGNED TO PARALEGAL |
06th May 2008 | PAPER RECEIVED |
06th May 2008 | SEC 7 REQUEST FILED |
22nd Apr 2008 | REGISTERED-PRINCIPAL REGISTER |
14th Mar 2008 | ASSIGNED TO LIE |
14th Mar 2008 | LAW OFFICE REGISTRATION REVIEW COMPLETED |
22nd Feb 2008 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
04th Dec 2007 | STATEMENT OF USE PROCESSING COMPLETE |